Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Nektar Therapeutics    NKTR

Delayed Quote. Delayed  - 05/27 09:59:59 pm
15.17 USD   +1.81%
05/03 NEKTAR THERAPEU : Reports Financial Results for the First Quarter of..
04/28 NEKTAR THERAPEU : to Announce Financial Results for the First Quarte..
04/18 NEKTAR THERAPEU : Preclinical Data Presented at AACR Demonstrate tha..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

NEKTAR THERAPEUTICS : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2016 | 10:20pm CEST

Item 2.02 Results of Operations and Financial Condition.

On May 3, 2016, Nektar Therapeutics, a Delaware corporation ("Nektar"), issued a press release (the "Press Release") announcing its financial results for the quarter ended March 31, 2016. A copy of the Press Release is furnished herewith as Exhibit 99.1.

On April 28, 2016, Nektar announced that it would hold a Webcast conference call on May 3, 2016 to review financial results for the quarter ended March 31, 2016. This conference call is accessible through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com.

The information in this report, including the exhibit hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by Nektar Therapeutics, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.




Exhibit
Number     Description

99.1       Press Release titled "Nektar Therapeutics Reports Financial Results
           for the First Quarter of 2016" issued by Nektar Therapeutics on May 3,
           2016.

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on NEKTAR THERAPEUTICS
05/03 NEKTAR THERAPEUTICS : Results of Operations and Financial Condition, Financial S..
05/03 NEKTAR THERAPEUTICS : Reports Financial Results for the First Quarter of 2016
04/28 NEKTAR THERAPEUTICS : Preclinical Data Presented at AACR Demonstrate that Combin..
04/28 NEKTAR THERAPEUTICS : to Announce Financial Results for the First Quarter 2016 o..
04/18 NEKTAR THERAPEUTICS : Preclinical Data Presented at AACR Demonstrate that Combin..
03/17 NEKTAR THERAPEUTICS : Researchers Submit Patent Application, "Systems and Method..
03/10 NEKTAR THERAPEUTICS : Patent Issued for Identifying Dry Nebulizer Elements (USPT..
03/03 NEKTAR THERAPEUTICS : to Present at Cowen and Company's 36th Annual Health Care ..
03/01 NEKTAR THERAPEUTICS : Results of Operations and Financial Condition, Financial S..
03/01 NEKTAR THERAPEUTICS : reports 4Q loss
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials